GRK2 and Beta-Arrestins in Cardiovascular Disease: Established and Emerging Possibilities for Therapeutic Targeting

Publisher： Bentham Science Publishers

E-ISSN： 1874-4702|5|3|317-326

ISSN： 1874-4672

Source： Current Molecular Pharmacology, Vol.5, Iss.3, 2012-11, pp. : 317-326

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Nrf2 pathway against cardiovascular disease

By Li Jinqing   Ichikawa Tomonaga   Janicki Joseph S   Cui Taixing  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 7, 2009-07 ,pp. : 785-794

Informa Healthcare

Access to resources Recommend Favorite

Novel Therapeutic Approaches Targeting Matrix Metalloproteinases in Cardiovascular Disease

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 10, 2012-05 ,pp. : 1214-1221

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases

By Parajuli Nirmal   Ramprasath Tharmarajan   Patel Vaibhav B.   Wang Wang   Putko Brendan   Mori Jun   Oudit Gavin Y.  

Canadian Journal of Physiology and Pharmacology, Vol. 92, Iss. 7, 2014-01 ,pp. : 558-565

NRC Research Press

Access to resources Recommend Favorite

The therapeutic potential of targeting the glucagon-like peptide-2 receptor in gastrointestinal disease

By Hornby Pamela J   Moore Beverley A  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 5, 2011-05 ,pp. : 637-646

Informa Healthcare

Access to resources Recommend Favorite

The therapeutic potential of bradykinin B2 receptor agonists in the treatment of cardiovascular disease

By Heitsch Holger  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 5, 2003-05 ,pp. : 759-770

Informa Healthcare

Access to resources Recommend Favorite